Inimmune Advances Phase 2 Trial of INI-2004, Aiming to Transform Allergic Rhinitis Treatment#United_States#Missoula#Allergic_Rhinitis#INI-2004#Inimmune_Corporation
Inimmune Advances Phase 2 Trial of INI-2004, Aiming to Transform Allergic Rhinitis Treatment
Inimmune has completed enrollment in its Phase 2 trial for INI-2004, an innovative treatment for allergic rhinitis, expected to yield crucial data soon.
third-news.com
March 12, 2026 at 2:54 PM
Inimmune Advances Phase 2 Trial of INI-2004, Aiming to Transform Allergic Rhinitis Treatment#United_States#Missoula#Allergic_Rhinitis#INI-2004#Inimmune_Corporation